Kanaly Trust’s QIAGEN NV QGENF Stock Holding History

Kanaly Trust’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$22K	Sell	787 -41	-5%	-$1.15K	﹤0.01%	410
2016 Q3	$23K	Buy	828 +180	+28%	+$5K	﹤0.01%	402
2016 Q2	$14K	Buy	648 +348	+116%	+$7.52K	﹤0.01%	490
2016 Q1	$7K	Sell	300 -1,270	-81%	-$29.6K	﹤0.01%	618
2015 Q4	$43K	Buy	1,570 +684	+77%	+$18.7K	0.01%	300
2015 Q3	$23K	Buy	886 +771	+670%	+$20K	0.01%	427
2015 Q2	$3K	Hold	115	–	–	﹤0.01%	754
2015 Q1	$3K	Hold	115	–	–	﹤0.01%	595
2014 Q4	$3K	Buy	115 +53	+85%	+$1.38K	﹤0.01%	607
2014 Q3	$1K	Hold	62	–	–	﹤0.01%	811
2014 Q2	$2K	Buy	+62	New	+$2K	﹤0.01%	668

Other funds holding QGENF

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Kanaly Trust's QGENF Position: Q4 2016 in Review

Kanaly Trust reduced its QIAGEN NV (QGENF) stake by 5% in Q4 2016, selling an estimated $1.15K and leaving 787 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #410.

Kanaly Trust first reported a position in QGENF in Q2 2014 and has held it in 11 quarters since. The position peaked at $43K in Q4 2015. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

Kanaly Trust held 787 shares of QIAGEN NV worth $22K as of Q4 2016.
Kanaly Trust sold 41 QIAGEN NV shares in Q4 2016, an estimated $1.15K.
QIAGEN NV made up ﹤0.01% of Kanaly Trust's portfolio in Q4 2016, its #410 holding.
Kanaly Trust first reported a position in QIAGEN NV in Q2 2014 and has held it in 11 quarters since.
Kanaly Trust's QIAGEN NV position peaked at $43K in Q4 2015.
189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.